iS Clinical launches SPF innovation: PerfecTint Powder

Forget everything you know about SPF/makeup hybrids. The new iS Clinical PerfecTint Powder SPF 40 provides unprecedented multilevel protection with a hydrating matte finish.

By now, you’re probably well aware of iS Clinical, a skincare line that has quietly taken the beauty industry by storm and become one of the most coveted brands in the market. Used by dermatologists and skin professionals and adored by many an A-lister, this brand is backed by hard science, delivering highly effective, clinically validated skincare products that offer dramatic improvements to specific skin concerns.

iS Clinical’s skincare ethos involves four steps: cleanse, treat, hydrate and protect, and the range offers products in each of these categories for a variety of specific skin types. Every option in the iS Clinical collection offers pure, pharmaceutical- grade botanicals combined into powerful formulas, designed to promote healthy skin function at a cellular level.

So, it’s little wonder that their new product PerfecTint Powder SPF 40 has us excited. Available in five tints to match every skin tone, PerfecTint Powder provides silky, broad spectrum coverage and free radical protection to help protect skin against the visible signs of photoageing .

PerfecTint Powder: the new skin protectant

PerfecTint Powder’s unique fomulation provides superior hydration while minimising the appearance of pores and absorbing surface oil to create a flawless matte finish. It features iS Clinical’s botanical antioxidant Extremozyme® technology, which is clinically proven to help protect DNA from environmental stressors while providing penetrating hydration even in powder form. It’s ideal to use as the last step in your skincare or makeup regimen as well as on the go – excellent for sports, face, neck, decollete, scalp, you name it!

One of the brand’s fundamental points of difference is its independent clinical studies on the final formulations of its products, and PerfecTint Powder is no different. In a 2020 study*, the ability of PerfecTint Powder SPF 40 to protect the skin from the harmful effects of environmental exposure and pollution was evaluated using diesel particulate matter with a particle size below 0.18 um. This small pollution particle damages even the smallest subunits of skin at both cellular and subcellular levels and increases skin ageing. The authors note particle sizes of below 2.5 um are small enough to penetrate even into pores and between cells and cause far-reaching skin damage.

The study found that application of PerfecTint Powder SPF 40 protects against damage caused by pollution. Specifically, the authors stated the following benefits:

• Very strong antioxidant effects/oxidative stress protection/free radical protection
• Very strong anti-inflammatory protection
• Cytoprotective effects, especially when skin is exposed to environmental stressors
• Strengthens the epidermal barrier
• Regenerative and cellular renewal effects
• Inhibits melanogenesis and lessens pigmentation induced by oxidative damage and pollution (in addition to SPF effects which are also active here)
• Wound-healing effects
• Strong hydration effects
• Anti-ageing effects
• Additional benefits resulting from solar protection (SPF effects)

Key ingredients

Key ingredients of iS CLINICAL PerfecTint Powder SPF 40 include:

• Zinc Oxide 25%, a safe, physical broad spectrum UVA/UVB sunscreen ingredient which provides a physical barrier to reflect and absorb UV radiation;
• Calcium Sodium Borosilicate 5%, which provides light-diffusing properties that enhance skin protection against High-Energy Visible (HEV) light damage, such as blue light pollution;
• Hydroxyapatite 5%, which enhances UVA/UVB protection while providing defence against wrinkles and photoageing;
• Lycopodium Clavatum 1%, which helps improve skin hydration levels from the epidermis to the dermal-epidermal junction (DEJ); and
• Imperata Cylindrica Root Extract (Extremozyme) 1%, which optimises and reinforces collagen synthesis and moisture absorption in the skin. CBM
  

  ---

* Study performed at Genemarkers, LLC. Study summarised by Charlene DeHaven MD, Clinical Director, Innovative Skincare.